Costs of biomarker testing in advanced non‐small cell lung cancer: a global study comparing next‐generation sequencing and single‐gene testing

Umberto Malapelle, Chien‐Chin Chen, Enrique de Álava, Paul Hofman, Daniel Kazdal, Tae‐Jung Kim, Tony Kiat Hon Lim, Aleš Ryška, Angelica A Saetta, Ed Schuuring, Giancarlo Troncone, Michele Biscuola, Yi‐Lin Chen, Gek San Tan, Charles Hugo Marquette, Maria Michelli, Arja ter Elst, Hana Vošmiková, Joshua Kapp, Sebastian Gonzalez‐McQuire, Andromachi Giannopoulou, Jean Marie Franzini, Victoria Lucia Rabsiun Aramburu, Anna Baggi, Albrecht Stenzinger

Open source

DOI
10.1002/2056-4538.70018
Published
2025-03
Container
The Journal of Pathology: Clinical Research
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/2056-4538.70018,
  title = {Costs of biomarker testing in advanced non‐small cell lung cancer: a global study comparing next‐generation sequencing and single‐gene testing},
  author = {Umberto Malapelle and Chien‐Chin Chen and Enrique de Álava and Paul Hofman and Daniel Kazdal and Tae‐Jung Kim and Tony Kiat Hon Lim and Aleš Ryška and Angelica A Saetta and Ed Schuuring and Giancarlo Troncone and Michele Biscuola and Yi‐Lin Chen and Gek San Tan and Charles Hugo Marquette and Maria Michelli and Arja ter Elst and Hana Vošmiková and Joshua Kapp and Sebastian Gonzalez‐McQuire and Andromachi Giannopoulou and Jean Marie Franzini and Victoria Lucia Rabsiun Aramburu and Anna Baggi and Albrecht Stenzinger},
  year = {2025},
  journal = {The Journal of Pathology: Clinical Research},
  doi = {10.1002/2056-4538.70018},
  url = {https://doi.org/10.1002/2056-4538.70018}
}

RIS

TY  - JOUR
TI  - Costs of biomarker testing in advanced non‐small cell lung cancer: a global study comparing next‐generation sequencing and single‐gene testing
AU  - Umberto Malapelle
AU  - Chien‐Chin Chen
AU  - Enrique de Álava
AU  - Paul Hofman
AU  - Daniel Kazdal
AU  - Tae‐Jung Kim
AU  - Tony Kiat Hon Lim
AU  - Aleš Ryška
AU  - Angelica A Saetta
AU  - Ed Schuuring
AU  - Giancarlo Troncone
AU  - Michele Biscuola
AU  - Yi‐Lin Chen
AU  - Gek San Tan
AU  - Charles Hugo Marquette
AU  - Maria Michelli
AU  - Arja ter Elst
AU  - Hana Vošmiková
AU  - Joshua Kapp
AU  - Sebastian Gonzalez‐McQuire
AU  - Andromachi Giannopoulou
AU  - Jean Marie Franzini
AU  - Victoria Lucia Rabsiun Aramburu
AU  - Anna Baggi
AU  - Albrecht Stenzinger
PY  - 2025
JO  - The Journal of Pathology: Clinical Research
DO  - 10.1002/2056-4538.70018
UR  - https://doi.org/10.1002/2056-4538.70018
ER  - 

APA

Malapelle, U., Chen, C., Álava, E. D., Hofman, P., Kazdal, D., Kim, T., Lim, T. K. H., Ryška, A., Saetta, A. A., Schuuring, E., Troncone, G., Biscuola, M., Chen, Y., Tan, G. S., Marquette, C. H., Michelli, M., Elst, A. T., Vošmiková, H., Kapp, J., Gonzalez‐McQuire, S., Giannopoulou, A., Franzini, J. M., Aramburu, V. L. R., Baggi, A., & Stenzinger, A. (2025). Costs of biomarker testing in advanced non‐small cell lung cancer: a global study comparing next‐generation sequencing and single‐gene testing. The Journal of Pathology: Clinical Research. https://doi.org/10.1002/2056-4538.70018

Source records